Twist Bioscience: High Throughput Antibody Expression Service

Twist Helps to Accelerate Antibody Discovery Process

Date & Time

September 7, 2022 | 11 am SGT

Webinar Description

High throughput is a key advantage of phage display, but this advantage is squandered in labs not equipped to reformat, express, and purify large numbers of antibodies for characterization. With its High-Throughput Antibody Production Platform, Twist offers a gene-to-protein workflow that eliminates this bottleneck by enabling the production of tens to thousands of diverse antibodies for downstream biophysical and pharmacokinetic screening assays. At the core of this platform is Twist’s silicon-based DNA synthesis process, which can precisely and uniformly write thousands of genes in a single run.

What you will learn from this webinar:
  • How Twist bridges the throughput gap between hit identification and characterization in antibody development
  • How Twist’s DNA synthesis platform enables high-throughput antibody production
  • What antibody formats and specifications are available
  • Application case study: How Twist Biopharma team makes best use of the HT IgG Expression service

Webinar Registration
By registering to this webinar you  consent to receive email marketing communications from Twist Bioscience. For more information, please review Twist's Privacy Policy


Bernd Willems, Ph.D.
Libraries and SynBio Application Specialist, Twist Bioscience

Bernd studied Biology at the University of Cologne in Germany and went on to do his PhD at the National University in Singapore doing Developmental Genetics research in Zebrafish. He started his corporate career coordinating clinical trials at a German Hospital consortium and later worked as the Global Product Manager for QIAGEN's PCR portfolio. He then returned to Singapore to represent the German Biotech Startup AYOXXA in APAC and eventually joined Twist where he is now working as the Application Specialist for our Synthetic Biology portfolio comprising Genes, Oligo Pools and DNA Variant Libraries.

Zhen Han, Ph.D.
Staff Scientist, Twist Biopharma Protein Science and Cell Biology

Zhen Han received his Ph.D. in Pharmaceutical and Biomedical Sciences from University of Georgia, where he discovered and characterized novel activity of lysine acetyltransferases with biochemical, biophysical assays, and activity based proteomic profiling approaches. After graduate school, Zhen performed his postdoctoral studies at Scripps Research focusing on gut microbiome characterization with functional catabolic probes and structural analysis of anti-Malarial antibodies. Zhen is currently a Staff Scientist at Twist Biopharma and his interests are protein sciences and antibody drug discovery.
©. All Rights Reserved Twist Bioscience.